Follow-up biomonitoring after accidental exposure to acrylonitrile:- implications for protein adducts as a dose monitor for short-term exposures.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 16280213)

Published in Toxicol Lett on November 08, 2005

Authors

Michael Bader1, Renate Wrbitzky

Author Affiliations

1: Hannover Medical School, Department of Occupational Medicine, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. bader.michael@mh-hannover.de

Articles by these authors

Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid (2004) 2.50

Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver. Hum Pathol (2002) 0.89

Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone. Int Arch Occup Environ Health (2005) 0.88

Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. Environ Mol Mutagen (2002) 0.87

Advantages of the JobReha discharge letter: an instrument for improving the communication interface in occupational rehabilitation. Int Arch Occup Environ Health (2012) 0.83

Human volunteer study on the inhalational and dermal absorption of N-methyl-2-pyrrolidone (NMP) from the vapour phase. Arch Toxicol (2007) 0.80

Ambient monitoring and biomonitoring of workers exposed to N-methyl-2-pyrrolidone in an industrial facility. Int Arch Occup Environ Health (2005) 0.79

Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions. Arch Toxicol (2006) 0.77

Chemosensory effects during acute exposure to N-methyl-2-pyrrolidone (NMP). Toxicol Lett (2007) 0.76

Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites. Int Arch Occup Environ Health (2006) 0.75